Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Journal of Clinical Pharmacy and Therapeutics|December 23, 2021
Clinical practice guidelines for management of dual antiplatelet therapy in patients with noncardiac surgery: A critical appraisal using the AGREE II instrumentXin Wang, Borui Tang, Ying Liu, et al.
Expert Opinion on Drug Safety|August 4, 2022
Interstitial pneumonitis associated with EGFR/ ALK tyrosine kinase inhibitors used in non-small cell lung cancer: an observational, retrospective, pharmacovigilance studyZhuo Ma, Jie Pei, Yi Zhang, et al.
Thrombosis and Haemostasis|June 30, 2022
Risk of Thromboembolic Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-analysis of Randomized Controlled TrialsZhuo Ma, Ximu Sun, Yi Zhang, et al.
Infection and Drug Resistance|February 23, 2023
Evaluation of Tigecycline Utilization and Trends in Antibacterial Resistance from 2018 to 2021 in a Comprehensive Teaching Hospital in ChinaHong Zhou, Xiangyu Sun, Shaocheng Lyu, et al.
Frontiers in Pharmacology|June 11, 2024
Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting systemXiangyu Sun, Huaguang Wang, Xi Zhan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 1, 2024
Association of Severe Vitamin D Deficiency with Hospitalization in the Previous Year in Hospitalized Exacerbated COPD PatientsBoyu Li, Meishan Liu, Ying Wang, et al.
Analytical Chemistry|January 3, 2025
Enalomics: A Mass Spectrometry-Based Approach for Profiling, Identifying, and Semiquantifying Enals in Biological SamplesCongyu Ma, Wen Zhang, Jialong Jing, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 30, 2026
Impact of Severe Vitamin D Deficiency on Antibiotic Use in Hospitalized COPD Patients with Exacerbations: A Retrospective AnalysisBoyu Li, Meishan Liu, Bingqing Ren, et al.
International Journal of Clinical Pharmacy|January 11, 2020
Impact of 'Chief-Pharmacist System' on drug expenditures and rational drug useZhuo Ma, ZhiXia Zhao, ShuSen Sun, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 18, 2022
Metabolic, genetic, and pharmacokinetic parameters for the prediction of olanzapine efficacyLing Cong, Zirui Wan, Pengfei Li, et al.
Pageof 11